Director Ivan Delevic resigns from MedTech Acquisition Board; Thierry Thaure joins Audit Committee

TriSalus Life Sciences, Inc.

Ivan Delevic resigned from MedTech Acquisition Corp.'s Board of Directors and all positions effective March 4, 2022, not due to any disagreement.
Thierry Thaure appointed to the Audit Committee, joining Karim Karti and Manuel Aguero, all independent under Nasdaq rules.
The Board of Directors expressed gratitude for Delevic's service.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ivan Delevic

Director

TLSI · TriSalus Life Sciences, Inc.

Effective: 2022-03-04
Filed: March 8, 2022, 6:59 PM ET

On March 4, 2022, Ivan Delevic notified MedTech Acquisition Corporation (“MedTech” or the “Company”) that he was resigning as a member of the Company’s Board of Directors and all other positions with the Company effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ivan Delevic resigned as Director at TriSalus Life Sciences, Inc..

Action: resigned
Role: Director

Exact text from the filing

On March 4, 2022, Ivan Delevic notified MedTech Acquisition Corporation (“MedTech” or the “Company”) that he was resigning as a member of the Company’s Board of Directors and all other positions with the Company effective immediately.

View on SEC.gov

TriSalus Life Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-031154

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.